|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-3-12
|
|
pubmed:abstractText |
Chemotherapy with oxaliplatin, fluorouracil (5-FU) and leucovorin (LV) has proven efficacy in patients with advanced colorectal carcinoma (CRC), although the optimal dosage and administration schedule are still unclear. This phase II trial investigated the tolerability and activity of weekly oxaliplatin, high-dose infusional 5-FU and LV in pretreated patients with metastatic CRC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
355-60
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15015621-Aged,
pubmed-meshheading:15015621-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15015621-Colorectal Neoplasms,
pubmed-meshheading:15015621-Disease-Free Survival,
pubmed-meshheading:15015621-Dose-Response Relationship, Drug,
pubmed-meshheading:15015621-Drug Administration Schedule,
pubmed-meshheading:15015621-Female,
pubmed-meshheading:15015621-Fluorouracil,
pubmed-meshheading:15015621-Humans,
pubmed-meshheading:15015621-Infusions, Intravenous,
pubmed-meshheading:15015621-Leucovorin,
pubmed-meshheading:15015621-Male,
pubmed-meshheading:15015621-Middle Aged,
pubmed-meshheading:15015621-Neoplasm Metastasis,
pubmed-meshheading:15015621-Organoplatinum Compounds
|
|
pubmed:articleTitle |
Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology, National Institute of Cancer Research, Genova, Italy. silvana.chiara@istge.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
